X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
WOCKHARDT LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

WOCKHARDT LIMITED   (WOCK)


Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
wockhardt ltd. - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 724.7       No. of shares m 110.04
    Mkt Cap Rs m 79,740       % ch % -1.0
    Vol '000 136.8       % ch week % -0.7
    P/E X 45.8       % ch 1-mth % -3.6
    P/CF X 16.8       % ch 12-mth % -23.6
    EPS (TTM) Rs 15.8       52 week H/L Rs 1,129.0/627.0
(As on Mar 29, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs6222,1662,0701,9802,000 
Low Rs251598337455706 
Sales per share (Unadj.) Rs397.5511.9440.1407.2403.7 
Earnings per share (Unadj.) Rs31.3145.576.636.829.5 
Diluted earnings per shareRs31.1144.976.436.829.6 
Cash flow per share (Unadj.) Rs41.8156.689.450.042.4 
Dividends per share (Unadj.) Rs05.0010.0020.000 
Adj. dividends per shareRs0.004.989.9720.010.00 
Dividend yield (eoy) %00.40.81.60 
Book value per share (Unadj.) Rs64.8219.5299.1310.4323.4 
Adj. book value per shareRs64.5218.6298.3310.5324.8 
Shares outstanding (eoy) m109.44109.58109.75110.07110.51 
Bonus/Rights/Conversions  -ESOPESOPESOP- 
Price / Sales ratio x1.12.72.73.03.4 
Avg P/E ratio x13.99.515.733.145.9 
P/CF ratio (eoy) x10.48.813.524.331.9 
Price / Book Value ratio x6.76.34.03.94.2 
Dividend payout %03.413.154.40 
Avg Mkt Cap Rs m47,771151,429132,062133,983149,509 
No. of employees `0007.9NA8.66.87.4 
Total wages/salary Rs m5,7296,5597,6868,6899,443 
Avg. sales/employee Rs Th5,507.0NM5,616.76,557.76,048.6 
Avg. wages/employee Rs Th725.2NM893.81,271.41,280.2 
Avg. net profit/employee Rs Th433.8NM977.6592.5441.5 
  INCOME DATA
Net Sales Rs m43,50556,09448,30444,81544,614 
Other income Rs m233512384666970 
Total revenues Rs m43,73856,60648,68845,48145,584 
Gross profit Rs m13,55720,62510,2577,0945,038 
Depreciation Rs m1,1511,2211,3991,4541,426 
Interest Rs m2,6902,1548345521,012 
Profit before tax Rs m9,95017,7628,4085,7533,570 
Minority Interest Rs m00-21-78-65 
Prior Period Items Rs m11-6006 
Extraordinary Inc (Exp) Rs m-4,31676749800 
Tax Rs m2,2172,5824791,627255 
Profit after tax Rs m3,42715,9418,4074,0493,257 
Gross profit margin %31.236.821.215.811.3 
Effective tax rate %22.314.55.728.37.1 
Net profit margin %7.928.417.49.07.3 
  BALANCE SHEET DATA
Current assets Rs m24,81533,26933,55935,21639,906 
Current liabilities Rs m18,90917,73517,43217,73018,423 
Net working cap to sales %13.627.733.439.048.2 
Current ratio x1.31.91.92.02.2 
Inventory Days Days7569758390 
Debtors Days Days6462366098 
Net fixed assets Rs m34,73624,80530,02231,30035,832 
Share capital Rs m547548549550553 
"Free" reserves Rs m6,14121,53128,21929,97730,370 
Net worth Rs m7,09724,05632,82934,16835,739 
Long term debt Rs m27,06414,75211,02311,84816,542 
Total assets Rs m62,53860,22766,22069,38979,522 
Interest coverage x4.79.211.111.44.5 
Debt to equity ratio x3.80.60.30.30.5 
Sales to assets ratio x0.70.90.70.60.6 
Return on assets %9.830.014.06.65.4 
Return on equity %48.366.325.611.99.1 
Return on capital %24.453.322.213.58.7 
Exports to sales %27.820.912.810.011.6 
Imports to sales %6.75.17.86.24.5 
Exports (fob) Rs m12,09411,7406,1804,4715,177 
Imports (cif) Rs m2,8992,8433,7602,7731,990 
Fx inflow Rs m13,78914,58211,02610,7407,589 
Fx outflow Rs m4,0403,6244,3613,3562,878 
Net fx Rs m9,74910,9596,6657,3834,711 
  CASH FLOW
From Operations Rs m 13,438 15,324 14,763 3,550 716 
From Investments Rs m -3,055 10,854 -8,516 -2,066 -8,182 
From Financial Activity Rs m -8,266 -22,458 -6,013 -757 2,543 
Net Cashflow Rs m 2,118 3,720 234 727 -4,923 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for wockhardt limited

 Share Holding
Indian Promoters : 74.5%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 2.3%
FIIs : 7.7%
ADR/GDR : 0.1%
Free float : 15.4%
Shareholders : 67,757
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Wockhardt Towers, C/2-G Block, BKC, Bandra (E), Mumbai-400 051
    E-MAIL: investorrelations@wockhardt.com     WEB: www.wockhardt.com
    TELEPHONE: (022) 2653 4444     FAX: (022) 2652 3905
    SECTOR: PHARMACEUTICALS     GROUP: KHORAKIWALA
    TR AGENT: Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
    AUDITOR: Haribhakti & Co.
CHM: Habil Khorakiwala COMP SEC: V. R. Khetan YEAR OF INC: 1973 BSE CODE: 532300 FV (Rs): 5 DIV YIELD (%): -

More pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMAALEMBIC LTDSTRIDES SHASUN LTDDR. REDDYS LABAMAR REMEDIES


Today's Market

Sensex Finishes Firm; Automobile Stocks Fall on SC Verdict(Closing)

Indian share markets finished the trading day on a positive note. At the closing bell, the BSE Sensex closed higher by 122 points, whereas the NSE Nifty finished higher by 43 points.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - ADCOCK INGRAM COMPARISON

Compare Company With Charts

COMPARE WOCKHARDT LTD. WITH

MARKET STATS